doi: 10.3390/ijms232213675 93
Nevertheless, even the most effective marketed incretin, the GLP-1/GIP dual agonist tirzepatide, produces a maximum HbA1c reduction of ~2.6%, with fewer than half of participants in the SURPASS trials reaching normoglycemia (HbA1c 10%), vehicle-treated animals lost ~40% of body weight over 3 months, consistent with prior reports showing comparable reductions from ~40 g at week 10 to ~25 g by week 20 19
PH, pixel heterogeneity
Shortly after starting tirzepatide in October, she noticed what she at first thought were signs of typical injection site irritation: some redness and itching
But given that these side effects are very rare, taking vitamin B12 at bedtime should be fine unless sleep disruption becomes a persistent symptom after taking supplements
Yale Medicine physicians recommend the following: Confirm the indication: GLP-1 medications are approved for specific body mass index (BMI) thresholds and medical conditions